Comparative performance of mFI‐5 and mFI‐11 thresholds in predicting outcomes after holmium laser enucleation of the prostate
BJUI Compass · 2026-07 · 7 (7)
DOI: 10.1002/bco2.70244 ↗At a glance
Journal article in BJUI Compass, published online on 2026-07-08. Written by Hasim Bakbak and 8 co-authors. Institution: Desai Sethi Urology Institute University of Miami Miller School of Medicine Miami Florida USA. Cited 1 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY 4.0). Funded by: NCATS NIH HHS.
Abstract (original language)
Objectives
This work aimed to evaluate the safety and efficacy of holmium laser enucleation of the prostate across different degrees of frailty using the 11‐item and 5‐item modified frailty indices and to compare perioperative and postoperative outcomes across multiple frailty thresholds. Materials and Methods We retrospectively reviewed patients who underwent HoLEP at our institution between July 2017 and August 2025. Frailty was assessed using mFI‐11 (cutoffs ≥0.18, ≥0.27, ≥0.36) and mFI‐5 (≥0.40). Perioperative variables, functional outcomes, and postoperative complications were compared. Agreement between frailty definitions was assessed using Cohen's kappa. Logistic regression was used to evaluate complication risk.
Results
Among 857 patients, overall frailty burden was low ranging from 16.2% with mFI‐11 ≥0.36 to 52.6% with mFI‐11 ≥0.18, and 27.5% by mFI‐5 ≥0.40. Functional outcomes improved in all groups, though patients defined as frail by mFI‐11 ≥0.36 demonstrated less improvement in IPSS at 1 year and lower Qmax at select time points. Major complications were uncommon and did not demonstrate a consistent frailty gradient. Transfusion risk was higher only at mFI‐11 ≥0.36. Urinary tract infection showed a dose–response relationship with increasing mFI‐11, with approximately a 20% increase in odds per one‐point increase.
Conclusions
HoLEP is safe and effective across frailty definitions. Frailty cutoff selection meaningfully influences risk stratification, with mFI‐11 ≥0.36 providing the most clinically informative discrimination.
Subjects
Author keywords
Authors and institutions
- Desai Sethi Urology Institute University of Miami Miller School of Medicine Miami Florida USA.
Funding
- NCATS NIH HHS
Cite
APA
Bakbak, H., Singh, G., Abdelaziz, A., Williams, A., Velasquez Ospina, J., Katz, J. E., Marcovich, R., Wein, A. J., & Shah, H. N. (2026). Comparative performance of mFI‐5 and mFI‐11 thresholds in predicting outcomes after holmium laser enucleation of the prostate. BJUI Compass, 7(7). https://doi.org/10.1002/bco2.70244
Vancouver
Bakbak H, Singh G, Abdelaziz A, Williams A, Velasquez Ospina J, Katz JE, et al. Comparative performance of mFI‐5 and mFI‐11 thresholds in predicting outcomes after holmium laser enucleation of the prostate. BJUI Compass. 2026;7(7). doi:10.1002/bco2.70244
BibTeX
@article{Bakbak2026,
author = {Bakbak, Hasim and Singh, Gurpremjit and Abdelaziz, Ahmad and Williams, Adam and Velasquez Ospina, Juanita and Katz, Jonathan E and Marcovich, Robert and Wein, Alan Jerome and Shah, Hemendra N},
title = {Comparative performance of mFI‐5 and mFI‐11 thresholds in predicting outcomes after holmium laser enucleation of the prostate},
journal = {BJUI Compass},
year = {2026},
volume = {7},
number = {7},
doi = {10.1002/bco2.70244}
}
EUVIMED